FDAnews Drug Daily Bulletin

PHYTOMEDICAL'S ONGOING DIABETES RESEARCH VALIDATED BY NEW STUDY

April 19, 2006
A A

PhytoMedical Technologies, Inc. today announced a new study presented at Experimental Biology 2006 provided further new evidence of the beneficial effects and biochemical actions of certain compounds in cinnamon that improve insulin function, lower blood sugar levels and triglycerides (fatty acids in blood), and also act as anti-inflammatory agents, which may be useful in preventing or mitigating arthritis, allergies as well as other inflammatory diseases such as cardiovascular diseases.
Business Wire